Click for best price
Small Molecule Targeted Cancer Therapy Market Size, Share 2022
This report contains market size and forecasts of Small Molecule Targeted Cancer Therapy in Global, including the following market information:
Global Small Molecule Targeted Cancer Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Small Molecule Targeted Cancer Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Monoclonal Antibodies Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Small Molecule Targeted Cancer Therapy include OncoGenex Pharmaceuticals, Inc., Cytokinetics Inc., Hospira Inc., GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Bayer HealthCare AG and Abbott Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Small Molecule Targeted Cancer Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Small Molecule Targeted Cancer Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Small Molecule Targeted Cancer Therapy Market Segment Percentages, by Type, 2021 (%)
Monoclonal Antibodies
Small Molecules
Small Molecule Drug Conjugates
Global Small Molecule Targeted Cancer Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Small Molecule Targeted Cancer Therapy Market Segment Percentages, by Application, 2021 (%)
Lymphoma
Melanoma
Multiple Myeloma
Breast Cancer
Prostate Cancer
Other Cancers
Global Small Molecule Targeted Cancer Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Small Molecule Targeted Cancer Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Small Molecule Targeted Cancer Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Small Molecule Targeted Cancer Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
OncoGenex Pharmaceuticals, Inc.
Cytokinetics Inc.
Hospira Inc.
GlaxoSmithKline plc
Boehringer Ingelheim GmbH
Bayer HealthCare AG
Abbott Laboratories
| Report Attributes |
Report Details |
| Report Title |
Small Molecule Targeted Cancer Therapy Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Small Molecule Targeted Cancer Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Small Molecule Targeted Cancer Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Small Molecule Targeted Cancer Therapy Overall Market Size
2.1 Global Small Molecule Targeted Cancer Therapy Market Size: 2021 VS 2028
2.2 Global Small Molecule Targeted Cancer Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Small Molecule Targeted Cancer Therapy Players in Global Market
3.2 Top Global Small Molecule Targeted Cancer Therapy Companies Ranked by Revenue
3.3 Global Small Molecule Targeted Cancer Therapy Revenue by Companies
3.4 Top 3 and Top 5 Small Molecule Targeted Cancer Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Small Molecule Targeted Cancer Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Small Molecule Targeted Cancer Therapy Players in Global Market
3.6.1 List of Global Tier 1 Small Molecule Targeted Cancer Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Small Molecule Targeted Cancer Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Small Molecule Targeted Cancer Therapy Market Size Markets, 2021 & 2028
4.1.2 Monoclonal Antibodies
4.1.3 Small Molecules
4.1.4 Small Molecule Drug Conjugates
4.2 By Type - Global Small Molecule Targeted Cancer Therapy Revenue & Forecasts
4.2.1 By Type - Global Small Molecule Targeted Cancer Therapy Revenue, 2017-2022
4.2.2 By Type - Global Small Molecule Targeted Cancer Therapy Revenue, 2023-2028
4.2.3 By Type - Global Small Molecule Targeted Cancer Therapy Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Small Molecule Targeted Cancer Therapy Market Size, 2021 & 2028
5.1.2 Lymphoma
5.1.3 Melanoma
5.1.4 Multiple Myeloma
5.1.5 Breast Cancer
5.1.6 Prostate Cancer
5.1.7 Other Cancers
5.2 By Application - Global Small Molecule Targeted Cancer Therapy Revenue & Forecasts
5.2.1 By Application - Global Small Molecule Targeted Cancer Therapy Revenue, 2017-2022
5.2.2 By Application - Global Small Molecule Targeted Cancer Therapy Revenue, 2023-2028
5.2.3 By Application - Global Small Molecule Targeted Cancer Therapy Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Small Molecule Targeted Cancer Therapy Market Size, 2021 & 2028
6.2 By Region - Global Small Molecule Targeted Cancer Therapy Revenue & Forecasts
6.2.1 By Region - Global Small Molecule Targeted Cancer Therapy Revenue, 2017-2022
6.2.2 By Region - Global Small Molecule Targeted Cancer Therapy Revenue, 2023-2028
6.2.3 By Region - Global Small Molecule Targeted Cancer Therapy Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Small Molecule Targeted Cancer Therapy Revenue, 2017-2028
6.3.2 US Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.3.3 Canada Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.3.4 Mexico Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Small Molecule Targeted Cancer Therapy Revenue, 2017-2028
6.4.2 Germany Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.4.3 France Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.4.4 U.K. Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.4.5 Italy Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.4.6 Russia Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.4.7 Nordic Countries Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.4.8 Benelux Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Small Molecule Targeted Cancer Therapy Revenue, 2017-2028
6.5.2 China Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.5.3 Japan Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.5.4 South Korea Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.5.5 Southeast Asia Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.5.6 India Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Small Molecule Targeted Cancer Therapy Revenue, 2017-2028
6.6.2 Brazil Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.6.3 Argentina Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Small Molecule Targeted Cancer Therapy Revenue, 2017-2028
6.7.2 Turkey Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.7.3 Israel Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.7.4 Saudi Arabia Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
6.7.5 UAE Small Molecule Targeted Cancer Therapy Market Size, 2017-2028
7 Players Profiles
7.1 OncoGenex Pharmaceuticals, Inc.
7.1.1 OncoGenex Pharmaceuticals, Inc. Corporate Summary
7.1.2 OncoGenex Pharmaceuticals, Inc. Business Overview
7.1.3 OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Major Product Offerings
7.1.4 OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Revenue in Global Market (2017-2022)
7.1.5 OncoGenex Pharmaceuticals, Inc. Key News
7.2 Cytokinetics Inc.
7.2.1 Cytokinetics Inc. Corporate Summary
7.2.2 Cytokinetics Inc. Business Overview
7.2.3 Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Major Product Offerings
7.2.4 Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Revenue in Global Market (2017-2022)
7.2.5 Cytokinetics Inc. Key News
7.3 Hospira Inc.
7.3.1 Hospira Inc. Corporate Summary
7.3.2 Hospira Inc. Business Overview
7.3.3 Hospira Inc. Small Molecule Targeted Cancer Therapy Major Product Offerings
7.3.4 Hospira Inc. Small Molecule Targeted Cancer Therapy Revenue in Global Market (2017-2022)
7.3.5 Hospira Inc. Key News
7.4 GlaxoSmithKline plc
7.4.1 GlaxoSmithKline plc Corporate Summary
7.4.2 GlaxoSmithKline plc Business Overview
7.4.3 GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Major Product Offerings
7.4.4 GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Revenue in Global Market (2017-2022)
7.4.5 GlaxoSmithKline plc Key News
7.5 Boehringer Ingelheim GmbH
7.5.1 Boehringer Ingelheim GmbH Corporate Summary
7.5.2 Boehringer Ingelheim GmbH Business Overview
7.5.3 Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Major Product Offerings
7.5.4 Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Revenue in Global Market (2017-2022)
7.5.5 Boehringer Ingelheim GmbH Key News
7.6 Bayer HealthCare AG
7.6.1 Bayer HealthCare AG Corporate Summary
7.6.2 Bayer HealthCare AG Business Overview
7.6.3 Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Major Product Offerings
7.6.4 Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Revenue in Global Market (2017-2022)
7.6.5 Bayer HealthCare AG Key News
7.7 Abbott Laboratories
7.7.1 Abbott Laboratories Corporate Summary
7.7.2 Abbott Laboratories Business Overview
7.7.3 Abbott Laboratories Small Molecule Targeted Cancer Therapy Major Product Offerings
7.7.4 Abbott Laboratories Small Molecule Targeted Cancer Therapy Revenue in Global Market (2017-2022)
7.7.5 Abbott Laboratories Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Small Molecule Targeted Cancer Therapy Market Opportunities & Trends in Global Market
Table 2. Small Molecule Targeted Cancer Therapy Market Drivers in Global Market
Table 3. Small Molecule Targeted Cancer Therapy Market Restraints in Global Market
Table 4. Key Players of Small Molecule Targeted Cancer Therapy in Global Market
Table 5. Top Small Molecule Targeted Cancer Therapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Small Molecule Targeted Cancer Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Small Molecule Targeted Cancer Therapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Small Molecule Targeted Cancer Therapy Product Type
Table 9. List of Global Tier 1 Small Molecule Targeted Cancer Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Small Molecule Targeted Cancer Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Small Molecule Targeted Cancer Therapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Small Molecule Targeted Cancer Therapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Small Molecule Targeted Cancer Therapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Small Molecule Targeted Cancer Therapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Small Molecule Targeted Cancer Therapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Small Molecule Targeted Cancer Therapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2023-2028
Table 30. OncoGenex Pharmaceuticals, Inc. Corporate Summary
Table 31. OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Product Offerings
Table 32. OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Revenue (US$, Mn), (2017-2022)
Table 33. Cytokinetics Inc. Corporate Summary
Table 34. Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Product Offerings
Table 35. Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Revenue (US$, Mn), (2017-2022)
Table 36. Hospira Inc. Corporate Summary
Table 37. Hospira Inc. Small Molecule Targeted Cancer Therapy Product Offerings
Table 38. Hospira Inc. Small Molecule Targeted Cancer Therapy Revenue (US$, Mn), (2017-2022)
Table 39. GlaxoSmithKline plc Corporate Summary
Table 40. GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Product Offerings
Table 41. GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Revenue (US$, Mn), (2017-2022)
Table 42. Boehringer Ingelheim GmbH Corporate Summary
Table 43. Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Product Offerings
Table 44. Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Revenue (US$, Mn), (2017-2022)
Table 45. Bayer HealthCare AG Corporate Summary
Table 46. Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Product Offerings
Table 47. Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Revenue (US$, Mn), (2017-2022)
Table 48. Abbott Laboratories Corporate Summary
Table 49. Abbott Laboratories Small Molecule Targeted Cancer Therapy Product Offerings
Table 50. Abbott Laboratories Small Molecule Targeted Cancer Therapy Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Small Molecule Targeted Cancer Therapy Segment by Type in 2021
Figure 2. Small Molecule Targeted Cancer Therapy Segment by Application in 2021
Figure 3. Global Small Molecule Targeted Cancer Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Small Molecule Targeted Cancer Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Small Molecule Targeted Cancer Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Small Molecule Targeted Cancer Therapy Revenue in 2021
Figure 8. By Type - Global Small Molecule Targeted Cancer Therapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Small Molecule Targeted Cancer Therapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Small Molecule Targeted Cancer Therapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Small Molecule Targeted Cancer Therapy Revenue Market Share, 2017-2028
Figure 12. US Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Small Molecule Targeted Cancer Therapy Revenue Market Share, 2017-2028
Figure 16. Germany Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 17. France Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Small Molecule Targeted Cancer Therapy Revenue Market Share, 2017-2028
Figure 24. China Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. India Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Small Molecule Targeted Cancer Therapy Revenue Market Share, 2017-2028
Figure 30. Brazil Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Small Molecule Targeted Cancer Therapy Revenue Market Share, 2017-2028
Figure 33. Turkey Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Small Molecule Targeted Cancer Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Hospira Inc. Small Molecule Targeted Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Abbott Laboratories Small Molecule Targeted Cancer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
